Healthcare - Genomics & Precision Medicine
Companies in gene therapy, genetic testing, and personalized medicine platforms
Gene Therapy & Gene Editing60
RNA Therapeutics10
Genetic Testing & Diagnostics23
Precision Medicine Platforms49
 AZN | AstraZeneca PLC | Precision Medicine Platforms | $294.1b | $168.24 | +0.5% | 4.0K |
 TMO | Thermo Fisher Scientific, Inc. | Precision Medicine Platforms | $186.3b | $537.68 | 0.0% | 2 |
 DHR | Danaher Corporation | Precision Medicine Platforms | $134.8b | $200.95 | 0.0% | 22 |
 VRTX | Vertex Pharmaceuticals Inc | Gene Therapy & Gene Editing | $126.1b | $477.37 | 0.0% | 27 |
 REGN | Regeneron Pharmaceuticals Inc | Gene Therapy & Gene Editing | $65.4b | $649.11 | 0.0% | N/A |
 ALNY | Alnylam Pharmaceuticals, Inc. | RNA Therapeutics | $40.2b | $279.23 | 0.0% | 21 |
 NTRA | Natera, Inc. Common Stock | Genetic Testing & Diagnostics | $38.9b | $276.11 | 0.0% | 120 |
 WAT | Waters Corp | Precision Medicine Platforms | $36.8b | $374.42 | 0.0% | N/A |
 ILMN | Illumina Inc | Genetic Testing & Diagnostics | $26.6b | $187.38 | 0.0% | 59 |
 INSM | Insmed, Inc. | Gene Therapy & Gene Editing | $23.1b | $109.25 | 0.0% | 58 |
 LH | Labcorp Holdings Inc. | Genetic Testing & Diagnostics | $23.0b | $274.50 | 0.0% | N/A |
 GH | Guardant Health, Inc. Common Stock | Precision Medicine Platforms | $19.9b | $162.00 | 0.0% | 28 |
 BBIO | BridgeBio Pharma, Inc. Common Stock | Precision Medicine Platforms | $14.6b | $83.84 | 0.0% | N/A |
 IONS | Ionis Pharmaceuticals, Inc. Common Stock | RNA Therapeutics | $13.1b | $55.84 | 0.0% | 25 |
 RVTY | Revvity, Inc. | Precision Medicine Platforms | $12.4b | $111.36 | 0.0% | 222 |
 ARWR | Arrowhead Research Corporation | RNA Therapeutics | $11.5b | $71.72 | 0.0% | 33 |
 BMRN | BioMarin Pharmaceuticals Inc | Gene Therapy & Gene Editing | $11.1b | $59.05 | 0.0% | N/A |
 TECH | Bio-Techne Corp. | Precision Medicine Platforms | $11.0b | $71.48 | 0.0% | N/A |
 KRYS | Krystal Biotech, Inc. Common Stock | Gene Therapy & Gene Editing | $11.0b | $350.59 | 0.0% | N/A |
 TEM | Tempus AI, Inc. Class A Common Stock | Precision Medicine Platforms | $10.4b | $56.50 | 0.0% | 9.2K |
 NUVL | Nuvalent, Inc. Class A Common Stock | Precision Medicine Platforms | $9.8b | $123.96 | 0.0% | N/A |
 KYMR | Kymera Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $9.4b | $114.00 | 0.0% | 208 |
 PRAX | Praxis Precision Medicines, Inc. Common Stock | Precision Medicine Platforms | $9.3b | $327.55 | 0.0% | 57 |
 QGEN | QIAGEN N.V. | Genetic Testing & Diagnostics | $8.1b | $41.52 | 0.0% | 140 |
 LNTH | Lantheus Holdings, Inc | Precision Medicine Platforms | $7.2b | $104.30 | 0.0% | 495 |
 TWST | Twist Bioscience Corporation Common Stock | Precision Medicine Platforms | $6.4b | $92.74 | 0.0% | 24 |
 BLLN | BillionToOne, Inc. Class A Common Stock | Genetic Testing & Diagnostics | $5.5b | $137.65 | 0.0% | 5 |
 CRSP | CRISPR Therapeutics AG | Gene Therapy & Gene Editing | $5.4b | $51.45 | 0.0% | 479 |
 CAI | Caris Life Sciences, Inc. Common Stock | Precision Medicine Platforms | $5.0b | $17.64 | 0.0% | N/A |
 TXG | 10x Genomics, Inc. Class A Common Stock | Genetic Testing & Diagnostics | $4.9b | $45.75 | 0.0% | 72 |
 VCYT | Veracyte, Inc. | Genetic Testing & Diagnostics | $4.7b | $59.59 | 0.0% | 2 |
 FOLD | Amicus Therapeutics, Inc | Gene Therapy & Gene Editing | $4.5b | $14.49 | +0.0% | 3.5M |
 DYN | Dyne Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $3.7b | $24.07 | 0.0% | 102 |
 IDYA | IDEAYA Biosciences, Inc. Common Stock | Precision Medicine Platforms | $3.6b | $36.25 | 0.0% | N/A |
 BEAM | Beam Therapeutics Inc. Common Stock | Gene Therapy & Gene Editing | $3.5b | $30.80 | 0.0% | 224 |
 ADPT | Adaptive Biotechnologies Corporation Common Stock | Precision Medicine Platforms | $3.4b | $22.93 | 0.0% | 978 |
 QURE | uniQure N.V. | Gene Therapy & Gene Editing | $3.2b | $40.96 | 0.0% | 2.3K |
 NTLA | Intellia Therapeutics, Inc | Gene Therapy & Gene Editing | $2.4b | $12.96 | 0.0% | 8.2K |
 VCEL | Vericel Corporation | Gene Therapy & Gene Editing | $2.3b | $47.42 | 0.0% | 109 |
 WGS | GeneDx Holdings Corp. Class A Common Stock | Precision Medicine PlatformsGenetic Testing & Diagnostics | $2.0b | $65.22 | 0.0% | 8 |
 PGEN | Precigen, Inc. Common Stock | Gene Therapy & Gene Editing | $2.0b | $5.09 | 0.0% | N/A |
 TSHA | Taysha Gene Therapies, Inc. Common Stock | Gene Therapy & Gene Editing | $2.0b | $6.15 | 0.0% | 2 |
 NEO | NeoGenomics, Inc. | Genetic Testing & Diagnostics | $1.9b | $14.48 | 0.0% | N/A |
 SRPT | Sarepta Therapeutics,, Inc. Common Stock | Gene Therapy & Gene Editing | $1.9b | $17.52 | 0.0% | 91 |
 MAZE | Maze Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $1.7b | $30.04 | 0.0% | N/A |
 CDNA | CareDx, Inc. | Genetic Testing & DiagnosticsPrecision Medicine Platforms | $1.5b | $29.80 | 0.0% | 971 |
 PSNL | Personalis, Inc. Common Stock | Genetic Testing & Diagnostics | $1.4b | $16.11 | 0.0% | 332 |
 BLFS | BioLife Solutions Inc. | Gene Therapy & Gene Editing | $1.4b | $28.65 | 0.0% | 104 |
 MGTX | MeiraGTx Holdings plc Ordinary Shares | Gene Therapy & Gene Editing | $1.3b | $12.57 | 0.0% | N/A |
 AZTA | Azenta, Inc. | Genetic Testing & Diagnostics | $1.2b | $26.71 | 0.0% | 2 |